Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes

被引:24
作者
Narimatsu, S
Kobayashi, N
Masubuchi, Y
Horie, T
Kakegawa, T
Kobayashi, H
Hardwick, JP
Gonzalez, FJ
Shimada, N
Ohmori, S
Kitada, M
Asaoka, K
Kataoka, H
Yamamoto, S
Satoh, T
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Lab Hlth Chem, Okayama 700, Japan
[2] Chiba Univ, Fac Pharmaceut Sci, Lab Biopharmaceut, Chiba 260, Japan
[3] Chiba Univ, Fac Pharmaceut Sci, Fac Med, Biochem Lab, Chiba 260, Japan
[4] NCI, Mol Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
[5] Daiichi Kagaku Co, Technores Ctr, Ibaraki, Osaka, Japan
[6] Chiba Univ, Fac Med, Chiba Univ Hosp, Div Pharm, Chiba, Japan
[7] Kyoto Univ, Primate Res Inst, Div Mol Physiol, Aichi, Japan
[8] Biomed Res Inst, Chiba, Japan
关键词
CYP2D6; human liver microsomes; monkey liver microsomes; propranolol; enantioselectivity; heterologous expression system;
D O I
10.1016/S0009-2797(00)00174-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined and compared enantioselectivity in the oxidation of propranolol (PL) by liver microsomes from humans and Japanese monkeys (Macaca fuscata). PL was oxidized at the naphthalene ring to 4-hydroxypropranolol, 5-hydroxypropranolol and side chain N-desisopropylpropranolol by human liver microsomes with enantioselectivity of [R(+)> S(-)] in PL oxidation rates at substrate concentrations of 10 mu M and 1 mM. In contrast, reversed enantioselectivity [R(+)< S(-)] in PL 5-hydroxylation and N-desalkylation rates at the same substrate concentrations was observed in monkey liver microsomes, although the selectivity was the same for PL 4-hydroxylation between the two species. All oxidation reactions of the PL enantiomers in human liver microsomes showed biphasic kinetics, i.e. the reactions could be expressed as the summation of a low-K-m phase and a high-K-m phase. Inhibition studies using antibodies and characterization of CYP2D6 enzymes expressed in insect cells or human lymphoblastoid cells indicated that the enantioselectivity of PL oxidation, especially the ring 4- and 5-hydroxylations reflected the properties of CYP2D6 in human liver microsomes. In monkey liver microsomes, all of the oxidation reactions of S( -)-PL showed biphasic kinetics, whereas ring 4- and 5-hydroxylations were monophasic and side chain N-desisopropylation was biphasic for R(+)-PL. Similarly, from the results of inhibition studies using antibodies and inhibitors of cytochrome P450 (P450), it appears that the reversed selectivity [R(+)<S(-)] of PL oxidation rates is catalyzed by CYP2D enzyme(s) in monkey liver at low substrate concentrations. These results indicate that different properties of P450s: belonging to the 2D subfamily cause the reversed enantioselectivity between human and monkey liver microsomes. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 90
页数:18
相关论文
共 44 条
  • [1] BULLOCK P, 1995, DRUG METAB DISPOS, V23, P736
  • [2] BUTERS JTM, 1994, DRUG METAB DISPOS, V22, P688
  • [3] Chen LP, 1997, DRUG METAB DISPOS, V25, P399
  • [4] COMPARISON OF SUBSTRATE METABOLISM BY WILD-TYPE CYP2D6 PROTEIN AND A VARIANT CONTAINING METHIONINE, NOT VALINE, AT POSITION-374
    CRESPI, CL
    STEIMEL, DT
    PENMAN, BW
    KORZEKWA, KR
    FERNANDEZSALGUERO, P
    BUTERS, JTM
    GELBOIN, HV
    GONZALEZ, FJ
    IDLE, JR
    DALY, AK
    [J]. PHARMACOGENETICS, 1995, 5 (04): : 234 - 243
  • [5] Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol
    Ellis, SW
    Rowland, K
    Ackland, MJ
    Rekka, E
    Simula, AP
    Lennard, MS
    Wolf, CR
    Tucker, GT
    [J]. BIOCHEMICAL JOURNAL, 1996, 316 : 647 - 654
  • [6] FUJITA S, 1993, J PHARMACOL EXP THER, V264, P226
  • [7] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM
    GONZALEZ, FJ
    SKODA, RC
    KIMURA, S
    UMENO, M
    ZANGER, UM
    NEBERT, DW
    GELBOIN, HV
    HARDWICK, JP
    MEYER, UA
    [J]. NATURE, 1988, 331 (6155) : 442 - 446
  • [8] GONZALEZ FJ, 1996, CYTOCHROMES P450 MET, P183
  • [9] Marmoset liver cytochrome P450s: Study for expression and molecular cloning of their cDNAs
    Igarashi, T
    Sakuma, T
    Isogai, M
    Nagata, R
    Kamataki, T
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 339 (01) : 85 - 91
  • [10] CYTOCHROME-P450IID SUBFAMILY IN NONHUMAN-PRIMATES - CATALYTICAL AND IMMUNOLOGICAL CHARACTERIZATION
    JACQZAIGRAIN, E
    GUEGUEN, M
    ZANGER, UM
    ROBIEUX, I
    ALVAREZ, F
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) : 1657 - 1663